0
Summaries for Patients |

Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group FREE

[+] Article and Author Information

The summary below is from the full report titled “Medical Management of the Acute Radiation Syndrome: Recommendations of the Strategic National Stockpile Radiation Working Group.” It is in the 15 June 2004 issue of Annals of Internal Medicine (volume 140, pages 1037-1051). The authors are J.K. Waselenko, T.J. MacVittie, W.F. Blakely, N. Pesik, A.L. Wiley, W.E. Dickerson, H. Tsu, D.L. Confer, C.N. Coleman, T. Seed, P. Lowry, J.O. Armitage, and N. Dainiak.


Ann Intern Med. 2004;140(12):I-51. doi:10.7326/0003-4819-140-12-200406150-00006
Text Size: A A A

Who developed these guidelines?

The Strategic National Stockpile (SNS) is a government-sponsored organization that works with government and nongovernment partners to upgrade the public health capacity of the United States to respond to national emergencies. One mission of the SNS is to supply large quantities of essential medical material to the public during an emergency.

What is the problem and what is known about it so far?

Radioactive materials are among the potential weapons that terrorists might use in an attack. During such an attack, people could suffer from the acute radiation syndrome. This syndrome is the collection of bodily effects resulting from exposure to large amounts of radiation. The SNS developed recommendations to help health care professionals respond appropriately in the event of an attack involving radiation exposure.

How did the SNS Radiation Working Group develop these recommendations?

The SNS assembled a working group with representatives from the Centers for Disease Control and Prevention, the U.S. Armed Forces, and universities with expertise in acute radiation injury. The working group reviewed published information and met during face-to-face and telephone conferences to discuss the recommendations.

What did the authors find?

Information about the acute radiation syndrome comes from studies of animals, studies of accidents at nuclear power plants, or studies of the effects of the atomic bomb detonated over Hiroshima, Japan. Published information supports a strategy in which health care providers first assess the radiation dose to an individual patient on the basis of symptoms and blood counts during the days after exposure. Body systems most affected in the acute radiation syndrome include the blood-producing system, the digestive system, the brain, and the skin. Symptoms and consequences of the acute radiation syndrome vary depending on the amount of exposure but can include nausea, vomiting, diarrhea, confusion, skin burns, low blood pressure or shock, infections, breathing difficulty, and death.

What does the SNS Radiation Working Group suggest that patients and doctors do?

If an event involving radioactive materials occurs, health care providers should evaluate patients' likely degree of exposure by monitoring their symptoms and blood counts. When the degree of exposure is high, the patient is almost certain to die. In such cases, the goal of treatment should be only to make the patient comfortable. In less severe exposures, treatment with blood transfusions; substances called hematopoietic cytokines to stimulate the production of blood cells; and, in some cases, stem-cell transfusions may increase survival rates. Other treatments include antibiotics to fight infections, medicines to decrease nausea and vomiting, skin care, and pain medications. Treatment of pregnant patients should consider the risks to the fetus. If the exposure involves substances called radioiodines, the victims can be at risk for thyroid cancer. Treatment with potassium iodide can reduce the risk for thyroid cancer. Psychological support is also an important part of treatment. Health care providers should refer to the official recommendations document at http://www.annals.org for more specific treatment recommendations and a list of additional resources.

What are the cautions related to these recommendations?

These recommendations may change as new information becomes available.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)